🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Joseph D. Schonhoft

Tagworks Pharmaceuticals (Netherlands)

ORCID: 0000-0002-5860-5040

Also affiliated with Epic Sciences (United States), Xilio Therapeutics (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial”.

Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

The Prostate(2021)10.1002/pros.24110
N/A
1.7DataRank · unranked
71 citations

Karim Boudadi, Wei Fu, Hao Wang, Rana Sullivan, Alice Jordan +12 more

Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer

Cancer Research(2020)10.1158/0008-5472.can-20-1216
N/A
0DataRank · unranked
42 citations

Jimmy L. Zhao, Adam Jendrisak, Emily Carbone, Ethan Barnett, Melanie Hullings +11 more

Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.183
N/A
0DataRank · unranked
2 citations

Susan Halabi, Joseph D. Schonhoft, Jun Luo, David M. Nanus, Paraskevi Giannakakou +13 more

Evaluating biomarkers in metastatic castration-resistant prostate cancer patients treated with enzalutamide: PSA, circulating tumor cell counts, AR-V7 status and radiographic progression.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e17569
N/A
0DataRank · unranked
1 citations

Fatima Karzai, Jennifer L. Marté, Marijo Bilušić, Sheri McMahon, Julius Strauss +13 more

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3471
N/A
0DataRank · unranked
37 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis

npj Precision Oncology(2021)10.1038/s41698-021-00211-1
N/A
0DataRank · unranked
34 citations

Sheng-Yu Ku, Luisa Fernandez, Angel Dago-Rodriquez, Jerry S. H. Lee, Adam Jendrisak +11 more

Schlafen 11 (SLFN11), a putative predictive biomarker of platinum/PARPi response, is frequently detected on circulating tumor cells (CTCs) in advanced prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17039
N/A
0DataRank · unranked
4 citations

Luisa Fernandez, Kate Cunningham, Natalie Elphick, Ethan Barnett, Jerry S. H. Lee +11 more

Data from Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

(2023)10.1158/1078-0432.c.6529986
N/A
0DataRank · unranked
0 citations

Tiziano Pramparo, Amir Mortazavi, Scot A. Niglio, Joseph D. Schonhoft, Adam Jendrisak +26 more

Data from Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

(2023)10.1158/1078-0432.c.6530474.v1
N/A
0DataRank · unranked
0 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinoma

npj Precision Oncology(2024)10.1038/s41698-024-00497-x
N/A
0DataRank · unranked
4 citations

Ian M. Silverman, Joseph D. Schonhoft, Adrienne Johnson, Pier Selenica, Danielle Ulanet +3 more

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2891
N/A
0DataRank · unranked
48 citations

Tiziano Pramparo, Amir Mortazavi, Scot A. Niglio, Joseph D. Schonhoft, Adam Jendrisak +26 more

Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma

npj Precision Oncology(2025)10.1038/s41698-025-01025-1
N/A
0DataRank · unranked
3 citations

Ian M. Silverman, Adrienne Johnson, Chenfeng Meng, Joseph D. Schonhoft, Michal Zimmermann +10 more